Schold, J D <br/><br/>
The burden of proof in the design of early phase clinical trials.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Jul 2013 
 - 1631-2 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.12304  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alefacept<br/>Graft Rejection--drug therapy<br/>Humans<br/>Immunosuppression Therapy--methods<br/>Kidney Transplantation<br/>Methylprednisolone--therapeutic use<br/>Mycophenolic Acid--analogs & derivatives<br/>Recombinant Fusion Proteins--therapeutic use<br/>Tacrolimus--therapeutic use